Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De-escalation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04557306
What this trial is testing

Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer

Who this might be right for
Solid Tumor
CHABiotech CO., Ltd 6
Not applicableStudy completedNCT04508296
What this trial is testing

The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality

Who this might be right for
ARDS, HumanSepsis, Severe
Northern State Medical University 46
Large-scale testing (Phase 3)Looking for participantsNCT05696093
What this trial is testing

Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit

Who this might be right for
Ventilator Associated Pneumonia
Assistance Publique - Hôpitaux de Paris 628
Testing effectiveness (Phase 2)Looking for participantsNCT06078384
What this trial is testing

Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

Who this might be right for
Triple-negative Breast Cancer
UNICANCER 354
Not applicableActive Not RecruitingNCT03311451
What this trial is testing

C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.

Who this might be right for
Barrett Esophagus
Merit Medical Systems, Inc. 62
Large-scale testing (Phase 3)Looking for participantsNCT06092957
What this trial is testing

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

Who this might be right for
Nasopharyngeal CarcinomaDe-escalation Therapy
Sun Yat-sen University 504
Not applicableStudy completedNCT05058196
What this trial is testing

Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 104
Large-scale testing (Phase 3)Looking for participantsNCT04852887
What this trial is testing

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Who this might be right for
Stage I Breast Cancer
NRG Oncology 1,670
Post-approval studies (Phase 4)Not Yet RecruitingNCT07644234
What this trial is testing

Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Sichuan Provincial People's Hospital 3,836
Post-approval studies (Phase 4)Study completedNCT04485325
What this trial is testing

Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

Who this might be right for
Rheumatic Arthritis
Dr. Frank Behrens 92
Not applicableActive Not RecruitingNCT03210103
What this trial is testing

Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 61
Large-scale testing (Phase 3)Study completedNCT01626612
What this trial is testing

De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis

Who this might be right for
Severe Sepsis
Assistance Publique Hopitaux De Marseille 120
Post-approval studies (Phase 4)Looking for participantsNCT07631156
What this trial is testing

STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart FailureVentricular Dysfunction, Left
Kyungsub Song 80
Large-scale testing (Phase 3)Study completedNCT03683329
What this trial is testing

Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock

Who this might be right for
Critical CareCancer
Institut Paoli-Calmettes 398
Not applicableNot Yet RecruitingNCT06878196
What this trial is testing

CtDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasm
Obstetrics & Gynecology Hospital of Fudan University 20
Not applicableLooking for participantsNCT07572370
What this trial is testing

Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Royal College of Surgeons, Ireland 560
Post-approval studies (Phase 4)Looking for participantsNCT06588595
What this trial is testing

The Switching Antiplatelet-9 (SWAP-9) Study

Who this might be right for
Coronary Arterial Disease (CAD)
University of Florida 90
Testing effectiveness (Phase 2)Ended earlyNCT01593241
What this trial is testing

Therapy De-escalation in Seminoma Stage IIA/B

Who this might be right for
Seminoma
Swiss Cancer Institute 120
Not applicableLooking for participantsNCT03396718
What this trial is testing

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas

Who this might be right for
Head-and-neck Squamous Cell Carcinoma
Technische Universität Dresden 304
Post-approval studies (Phase 4)Looking for participantsNCT06584162
What this trial is testing

Subcutaneous Interval Lengthening of Vedolizumab for Economic Research

Who this might be right for
Inflammatory Bowel Diseases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Next Page